跳至主要内容
临床试验/CTRI/2023/09/057791
CTRI/2023/09/057791尚未招募3 期

Comparative study of treatment outcomes of patients of aplastic anemia with combination therapy cyclosporine A + danazol + eltrombopag vs cyclosporine A + danazol + high dose Romiplostim

Government of Uttar Pradesh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Confirmed cases of Aplastic anemia
  • 2. Patient age >15years
  • 3. Not willing for ASCT and ATG.
  • 4. Non- pregnant women.
  • 5. Those who consent to take part in the study.
  • 6. No hepatic or renal disease.
  • 7. No drug h/o that causes Myelo-suppression.

排除标准

  • 1. Previous history of HSCT,
  • 2. Patients eligible for HSCT
  • 3. Patients with HIV/ HCV/ HBV infections.
  • 4. Significant PNH clone and Myelodysplasia.

研究者

发起方
Government of Uttar Pradesh

相似试验

To find whether Romiplostim is useful in Aplastic... | 临床试验